FDA Adverse Event Injury Summary report: N

COOLSCULPTING SYSTEM

MDR report key: 23871495 · Received December 22, 2025

Report

Report Number
3007215625-2025-00893
Event Type
Injury
Date Received
December 22, 2025
Date of Event
August 1, 2025
Report Date
December 22, 2025
Manufacturer
ALLERGAN PLEASANTON
Product Code
OOK
UDI-DI
00816417020001
PMA / PMN Number
K160259
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
VA, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

PARADOXICAL ADIPOSE HYPERPLASIA (PH) IS A KNOWN POTENTIAL ADVERSE EVENT ADDRESSED IN THE PRODUCT LABELING. ACCORDING TO THE COOLSCULPTING USER MANUAL, UNDER RARE ADVERSE EVENTS, PH IS CHARACTERIZED BY A VISIBLY ENLARGED TISSUE VOLUME WITHIN THE TREATMENT AREA, WHICH MAY DEVELOP TWO TO FIVE MONTHS AFTER TREATMENT. SURGICAL INTERVENTION MAY BE REQUIRED. PH IS NOT RELATED TO ANY COOLSCULPTING DEVICE FAILURE MODE BUT IT IS INCLUDED IN THE RISK MANAGEMENT FILES OF THE DEVICE BECAUSE IT IS A RISK THAT IS INHERENT TO THE USE CRYOLIPOLYSIS FOR LOCALIZED FAT REDUCTION. A SUPPLEMENTAL REPORT WILL BE SUBMITTED IF AND WHEN ADDITIONAL INFORMATION IS OBTAINED. COOLSCULPTING SYSTEM SERIAL NUMBER: (B)(4) CATALOG NUMBER: SA16789 LOT NUMBER: NI UDI: (01)00816417020001(21) (B)(4)(11)230223(17)991231 MANUFACTURING DATE: 02/23/2023. COOLSCULPTING SYSTEM SERIAL NUMBER: (B)(4) CATALOG NUMBER: SA16789 LOT NUMBER: NI UDI: (01)00816417020001(21) (B)(4)(11)230223(17)991231 MANUFACTURING DATE: 02/23/2023.

Description of Event or Problem · 0

A PROVIDER REPORTED THAT A PATIENT RECEIVED A COOLSCULPTING TREATMENT TO THE SUBMENTAL AREA ON (B)(6) /2025 USING THE COOLMINI APPLICATOR AND PRESENTED WITH POSSIBLE PARADOXICAL HYPERPLASIA (PH) AND "ENLARGED AREA" 6 MONTHS POST TREATMENT. LATER HEALTHCARE PROFESSIONAL REPORTED "SOME TENDERNESS".

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2328843 COOLSCULPTING SYSTEM DERMAL COOLING PACK/VACUUM/MASSAGER OOK ALLERGAN PLEASANTON NI 00816417020001

Patients

Seq Age Sex Outcome Treatment
1 38 YR Female Required Intervention (B)(4)